Literature DB >> 25990458

A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.

Guangyu Ma1, Boya Zhong1,2,3, Shinya Okamoto2,4, Yuanyuan Jiang2,3, Kiyoko Kawamura2, Hongdan Liu2, Quanhai Li5,6, Masato Shingyoji7, Ikuo Sekine7, Yuji Tada4, Koichiro Tatsumi4, Hideaki Shimada8, Kenzo Hiroshima9, Masatoshi Tagawa10,11.   

Abstract

Type 5 adenoviruses expressing mda-7 gene (Ad-mda-7) induced cell death in various kinds of human tumors, but pancreatic carcinoma cells were relatively resistant to Ad-mda-7-mediated cytotoxicity. We then examined whether infection of Ad-mda-7 together with replication-competent Ad produced combinatory cytotoxic effects. We prepared replication-competent Ad, defective of the E1B55kDa gene or activated by a transcriptional regulatory region of the midkine or the survivin gene of which the expression was up-regulated in human tumors. Type 5 Ad bearing the exogenous regulatory region were further modified by replacing the fiber-knob region with that of type 35 Ad. Pancreatic carcinoma cells were infected with replication-incompetent Ad-mda-7 and the replication-competent Ad. Combinatory effects were examined with the CalcuSyn software and cell cycle analyses. Ad-mda-7 and the replication-competent Ad achieved cytotoxicity to pancreatic carcinoma. A combinatory use of Ad-mda-7 and either Ad defective of the E1B55kDa gene or Ad activated by the regulatory region produced synergistic cytotoxic effects. Cell cycle analyses demonstrated that the combination increased sub-G1 populations. These data collectively suggest that expression of MDA-7 augments cytotoxicity of replication-competent Ad and achieves adjuvant effects on Ad-mediated cell death.

Entities:  

Keywords:  Cytotoxicity; MDA-7; Pancreatic carcinoma; Replication-competent adenovirus

Mesh:

Substances:

Year:  2015        PMID: 25990458     DOI: 10.1007/s13277-015-3555-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

Authors:  Lili Zhao; Jinfa Gu; Aiwen Dong; Yanhong Zhang; Liu Zhong; Lingfeng He; Yigang Wang; Jinhe Zhang; Zilai Zhang; Jin Huiwang; Qijun Qian; Cheng Qian; Xinyuan Liu
Journal:  Hum Gene Ther       Date:  2005-07       Impact factor: 5.695

2.  Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.

Authors:  Ling Yu; Hisanori Takenobu; Osamu Shimozato; Kiyoko Kawamura; Yoshinori Nimura; Naohiko Seki; Katsuhiro Uzawa; Hideki Tanzawa; Hideaki Shimada; Takenori Ochiai; Masatoshi Tagawa
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

Review 3.  Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.

Authors:  Luni Emdad; Irina V Lebedeva; Zhao-zhong Su; Pankaj Gupta; Moira Sauane; Rupesh Dash; Steven Grant; Paul Dent; David T Curiel; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Biol Ther       Date:  2009-03-08       Impact factor: 4.742

4.  Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene.

Authors:  Jingjing Luo; Qingmei Xia; Rui Zhang; Chen Lv; Wei Zhang; Yingxin Wang; Qiang Cui; Li Liu; Rong Cai; Cheng Qian
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

5.  Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.

Authors:  Minoru Tomizawa; Hiromitsu Saisho; Masatoshi Tagawa
Journal:  Anticancer Res       Date:  2003 Jul-Aug       Impact factor: 2.480

6.  Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma.

Authors:  Z Zhang; K Kawamura; Y Jiang; M Shingyoji; G Ma; Q Li; J Hu; Y Qi; H Liu; F Zhang; S Kang; B Shan; S Wang; S Chada; M Tagawa
Journal:  Cancer Gene Ther       Date:  2013-11-22       Impact factor: 5.987

Review 7.  Conditionally replicating adenoviruses for cancer treatment.

Authors:  Youssef Jounaidi; Joshua C Doloff; David J Waxman
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

8.  Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.

Authors:  K-J Zhang; J Zhang; Y-M Wu; J Qian; X-J Liu; L-C Yan; X-M Zhou; R-J Xiao; Y-G Wang; X Cao; N Wei; X-R Liu; B Tang; X-Y Jiao; K Chen; X-Y Liu
Journal:  Cancer Gene Ther       Date:  2012-07-13       Impact factor: 5.987

Review 9.  mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.

Authors:  Rupesh Dash; Sujit K Bhutia; Belal Azab; Zhao-zhong Su; Bridget A Quinn; Timothy P Kegelmen; Swadesh K Das; Keetae Kim; Seok-Geun Lee; Margaret A Park; Adly Yacoub; Mohammed Rahmani; Luni Emdad; Igor P Dmitriev; Xiang-Yang Wang; Devanand Sarkar; Steven Grant; Paul Dent; David T Curiel; Paul B Fisher
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

10.  Clinical significance of midkine expression in pancreatic head carcinoma.

Authors:  S Maeda; H Shinchi; H Kurahara; Y Mataki; H Noma; K Maemura; K Aridome; T Yokomine; S Natsugoe; T Aikou; S Takao
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.